- Home
- PULM vs YMAT Comparison
PULM vs YMAT Comparison
Compare PULM & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PULM | YMAT |
|---|---|---|
| Founded | 2003 | 1970 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 7.3M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PULM | YMAT |
|---|---|---|
| Price | $1.68 | $1.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 41.9K | ★ 1.8M |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,910,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.92 |
| Revenue Growth | ★ 5069.93 | N/A |
| 52 Week Low | $1.16 | $0.24 |
| 52 Week High | $5.50 | $2.94 |
Technical Indicators
Market Signals| Indicator | PULM | YMAT |
|---|---|---|
| Relative Strength Index (RSI) | 58.66 | 48.01 |
| Support Level | $1.61 | $1.57 |
| Resistance Level | $1.66 | $2.30 |
| Average True Range (ATR) | 0.10 | 0.41 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 67.27 | 49.66 |
Price Performance
Historical ComparisonAbout PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About YMAT J-Star Holding Co. Ltd. Ordinary Shares
J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.